Breaking News Instant updates and real-time market news.

UNH

UnitedHealth

$152.11

-0.7 (-0.46%)

, CVS

CVS Health

$74.78

0.72 (0.97%)

08:45
11/29/16
11/29
08:45
11/29/16
08:45

OptumRx, CVS Pharmacy partner to expand consumer choice, reduce costs

OptumRx and CVS Pharmacy are partnering to provide more convenient choices and lower costs for consumers and clients while improving health outcomes. OptumRx is UnitedHealth Group's (UNH) free-standing pharmacy care services business, managing more than one billion prescriptions annually. CVS Pharmacy, the retail division of CVS Health (CVS), has more than 9,600 retail pharmacies across the nation. The strategic relationship will bring together complementary capabilities to provide greater convenience and value. Together, the two companies will offer employers a new pharmacy network solution that: Provides eligible OptumRx members the option to fill 90-day prescriptions at prices equal to home delivery copay levels at CVS locations nationwide or through OptumRx home delivery; Increases consumer engagement and improves health outcomes through the combination of OptumRx's leading pharmacy and clinical solutions with CVS Pharmacy's leading in-store health and wellness capabilities; Enables OptumRx and CVS Pharmacy to leverage a shared pharmacy platform to develop new pharmacy and health solutions for clients and consumers. OptumRx and CVS expect the new 90-day pharmacy solution to be available to OptumRx commercial clients implementing new 90-day prescription benefit designs, beginning July 1, 2017.

UNH

UnitedHealth

$152.11

-0.7 (-0.46%)

CVS

CVS Health

$74.78

0.72 (0.97%)

  • 29

    Nov

UNH UnitedHealth
$152.11

-0.7 (-0.46%)

10/19/16
LEER
10/19/16
NO CHANGE
Target $175
LEER
Outperform
UnitedHealth price target raised to $175 from $165 at Leerink
Leerink analyst Ana Gupte raised her price target for UnitedHealth to $175 from $165 after the company reported a "solid beat and raise" Q3, giving her more confidence in the strength of the company's diversified platform and execution while also offering positive read-across for Commercial Fully Insured & Individual fundamentals to the rest of the group. The analyst reiterates an Outperform rating on the shares.
11/09/16
MZHO
11/09/16
DOWNGRADE
MZHO
Neutral
UnitedHealth downgraded to Neutral from Buy at Mizuho
11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
11/09/16
MZHO
11/09/16
DOWNGRADE
Target $135
MZHO
Neutral
UnitedHealth downgraded to Neutral on Republican win at Mizuho
As previously reported, Mizuho analyst Sheryl Skolnick downgraded UnitedHealth to Neutral from Buy citing Donald Trump's election and the move to a GOP Congress. Following the election results, Skolnick sees an "extreme risk" for the ACA to be repealed and replaced and for the loss of the Medicaid expansion, both of which she notes have been primary drivers of results for hospitals and health plans. She cut her price target on the stock to $135 from $169.
CVS CVS Health
$74.78

0.72 (0.97%)

10/06/16
10/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with an Outperform at Baird. 2. AMC Networks (AMCX) initiated with an Outperform at FBN Securities. 3. CVS Health (CVS) initiated with a Buy at UBS. 4. L-3 Communications (LLL) initiated with an Outperform at Baird. 5. Raytheon (RTN) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/13/16
LEER
10/13/16
NO CHANGE
Target $105
LEER
Outperform
Tricare announcement not material to CVS Health, says Leerink
Leerink analyst David Larsen notes that Tricare recently announced that CVS Health (CVS) will be excluded from its network effective December 1 and Walgreens Boots Alliance (WBA) will be in-network. While there are over 127M scripts associated with Tricare each year, the analyst estimates that just about 30.6M of these prescriptions are "retail" and as a result Larsen does not believe that CVS' exclusion from the Tricare network will be material. He remains positive on CVS, and reiterates an Outperform rating and $105 price target on the company's shares.
11/09/16
COWN
11/09/16
NO CHANGE
Target $86
COWN
Outperform
CVS Health weakness a buying opportunity, says Cowen
Cowen analyst Charles Ryhee said he would be a buyer of CVS Health on weakness. He said he expects little downside risk to management's guidance and wouldn't be surprised to see upside from PBM given the strong selling season. Ryhee maintained his Outperform rating and lowered his price target to $86 from $105 on CVS Health shares.
11/15/16
LEER
11/15/16
NO CHANGE
Target $85
LEER
Outperform
CVS Health price target lowered to $85 from $105 at Leerink
Leerink analyst David Larsen lowered his price target for CVS Health (CVS) to $85 from $105 as he is incrementally more cautious on the company. Conversely, the analyst is incrementally more positive on Walgreens Boots Alliance (WBA) and believes its deal with Rite Aid (RAD) deal is more likely to go through with Trump as President. Nonetheless, Larsen believes that 2017 is largely a re-set year for CVS Health, and expects the business to return to more robust growth in 2018 and beyond. He reiterates an Outperform rating on CVS Health's shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:12
09/25/17
09/25
09:12
09/25/17
09:12
Hot Stocks
Amazon signs multi-year deal with Amy Sherman-Palladino, Daniel Palladino »

Amazon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

MSM

MSC Industrial

09:11
09/25/17
09/25
09:11
09/25/17
09:11
Initiation
MSC Industrial initiated  »

MSC Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

LH

LabCorp

, DGX

Quest Diagnostics

09:10
09/25/17
09/25
09:10
09/25/17
09:10
Recommendations
LabCorp, Quest Diagnostics analyst commentary  »

LabCorp, Quest should be…

LH

LabCorp

DGX

Quest Diagnostics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

BSFT

BroadSoft

$49.75

-0.25 (-0.50%)

09:10
09/25/17
09/25
09:10
09/25/17
09:10
Hot Stocks
P2 Capital Partners reports 7.3% stake in BroadSoft, may hold talks »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

CC

Chemours

$51.79

-0.16 (-0.31%)

09:09
09/25/17
09/25
09:09
09/25/17
09:09
Hot Stocks
Chemours CEO Vergnano elected to chair board of the National Safety Council »

The Chemours Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$189.28

-1.04 (-0.55%)

, ESYJY

easyJet

$65.04

-0.65 (-0.99%)

09:08
09/25/17
09/25
09:08
09/25/17
09:08
Hot Stocks
L3 Technologies selected by easyJet to provide flight training »

L3 Technologies (LLL)…

LLL

L3 Technologies

$189.28

-1.04 (-0.55%)

ESYJY

easyJet

$65.04

-0.65 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.54

-0.57 (-0.33%)

09:08
09/25/17
09/25
09:08
09/25/17
09:08
Recommendations
Facebook analyst commentary  »

Facebook online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

CMCSA

Comcast

$38.10

0.63 (1.68%)

, CMCSK

Comcast

09:08
09/25/17
09/25
09:08
09/25/17
09:08
Hot Stocks
Comcast, LG partner for Xfinity TV subscription on LG TVs »

Comcast and LG…

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

SPA

Sparton

$23.35

0.11 (0.47%)

09:07
09/25/17
09/25
09:07
09/25/17
09:07
Hot Stocks
Sparton, Ultra receive requests for additional information from DOJ »

Ultra Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

PKD

Parker Drilling

$1.20

0.05 (4.35%)

, LYB

LyondellBasell

$96.87

1.08 (1.13%)

09:07
09/25/17
09/25
09:07
09/25/17
09:07
Hot Stocks
Parker Drilling names Michael Sumruld as CFO, effective October 1 »

Parker Drilling (PKD)…

PKD

Parker Drilling

$1.20

0.05 (4.35%)

LYB

LyondellBasell

$96.87

1.08 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 16

    May

09:06
09/25/17
09/25
09:06
09/25/17
09:06
Conference/Events
Wells Fargo healthcare analysts hold an analyst/industry conference call »

Healthcare Analysts,…

ICPT

Intercept

$61.59

-12.11 (-16.43%)

09:06
09/25/17
09/25
09:06
09/25/17
09:06
Hot Stocks
Intercept says black box possible, not expecting restrictive label changes »

Intercept Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

JAGX

Jaguar Health

$0.41

0.0187 (4.79%)

09:06
09/25/17
09/25
09:06
09/25/17
09:06
Hot Stocks
Jaguar subsisidary Napo, Glenmark sign agreement regarding Mytesi rights »

Jaguar Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVD

American Vanguard

$21.75

0.3 (1.40%)

09:05
09/25/17
09/25
09:05
09/25/17
09:05
Hot Stocks
American Vanguard subsidiary to acquire OHP »

American Vanguard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STI

SunTrust

$57.22

0.21 (0.37%)

09:05
09/25/17
09/25
09:05
09/25/17
09:05
Hot Stocks
SunTrust announces sale of Premium Assignment Corporation »

SunTrust Banks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

09:05
09/25/17
09/25
09:05
09/25/17
09:05
General news
U.S. equities are moderately lower »

U.S. equities are…

WSM

Williams-Sonoma

$46.78

0.17 (0.36%)

09:04
09/25/17
09/25
09:04
09/25/17
09:04
Hot Stocks
Williams-Sonoma Home to open store in New York City »

Williams Sonoma Home, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$185.76

-0.88 (-0.47%)

09:04
09/25/17
09/25
09:04
09/25/17
09:04
Hot Stocks
Amgen updates impact of Hurricane Maria in Puerto Rico »

Amgen provided an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 08

    Nov

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ESPGY

Esprit Holdings

$1.14

-0.068 (-5.63%)

09:03
09/25/17
09/25
09:03
09/25/17
09:03
Conference/Events
Esprit Holdings management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

FIT

Fitbit

$6.31

0.02 (0.32%)

09:03
09/25/17
09/25
09:03
09/25/17
09:03
Hot Stocks
Fitbit announces global availability of Fitbit Ionic, Fitbit Flyer »

Fitbit announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

C

Citi

$71.40

-0.36 (-0.50%)

09:03
09/25/17
09/25
09:03
09/25/17
09:03
Hot Stocks
Citi Commercial Cards awarded GSA SmartPay 3 Master Contract »

Citi has been awarded the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

MA

MasterCard

$141.89

0.17 (0.12%)

09:02
09/25/17
09/25
09:02
09/25/17
09:02
Hot Stocks
MasterCard, Swarovski launch virtual reality shopping experience »

Mastercard and Swarovski…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AJG

Arthur J. Gallagher

$60.99

0.32 (0.53%)

09:01
09/25/17
09/25
09:01
09/25/17
09:01
Hot Stocks
Arthur J. Gallagher acquires Lutgert Insurance, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$79.92

0.03 (0.04%)

09:01
09/25/17
09/25
09:01
09/25/17
09:01
Hot Stocks
Exxon Mobil expands methane emissions reduction program »

ExxonMobil announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

KMX

CarMax

$74.19

5.35 (7.77%)

09:00
09/25/17
09/25
09:00
09/25/17
09:00
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.